It is EHPs stated editorial policy to serve as a forum for discussion of issues of environmental health, encouraging the expression of scientific opinion and fostering healthy scientific debate. Your editorial policy states that "all scientific articles are subject to rigorous peer review. The primary criteria are environmental significance and scientific quality." Based on these criteria, it appears that the journal has failed to hold the paper of Lieberman et al. (1) to these standards. This paper is a blatant and deliberate misdirection of the reader, providing misinterpretation of a poorly designed study that is not up to the standards of modern toxicology or EHP.
Lieberman et al. (1) indicate that they distilled breast implant gel at 180°C at reduced pressure for 24 hr and imply that this material represents what would leak from implants. It is well known that silicone polymers can thermally depolymerize to form cyclic siloxanes under the authors' distillation conditions (2) , but this does not represent "real life" conditions. Lieberman et al. (1) values greater than these dose levels are considered to be virtually nontoxic.
If this misinterpretation of toxicity data were to remain quietly in the annals of EHP, it would be merely a problem of editorial carelessness. However, this paper has been picked up by several of the news services (e.g., Reuters, BBC), with online and print media declaring "Silicones Kill Mice!" and no longer noting that the dose and dose route are responsible for the lethality, not the inherent toxicity of the material. By publishing this paper, EHP has become a source for junk science reporters. (1) reported that a distillate from an explanted breast implant contains anywhere from 2 to 60% cyclosiloxanes, with CS-D4 being present at the highest concentration. It is well known that destructive distillation of a siloxane polymer or gel at high temperature under vacuum "cracks" the polymer causing, under these destructive conditions, the formation of large amounts of cyclosiloxanes (2) . There is no doubt that the low molecular weight cyclosiloxanes collected by Lieberman et al. (1) were created during the distillation by a "cracking" process. The conditions required to crack a polymer do not exist in the human body. Our own analysis of an intact silicone breast implant shows that CS-D4 levels rarely, if ever, exceed approxmately 700 ppm (i.e., 700 pg/g). Migration of CS-D4 from an implant occurs at a rate of about 0.58 pg/day (3) which, for a 60-kg women, equates to a 0.0 10 pg/kg/day exposure to CS-D4.
Lieberman et al. (1) (1) . This is based on the unrealistic assumption that all of the CS-D4 in an implant would be released at one time.
The histopathologic findings reported by Lieberman et al. (1) Table 2 (1), the highest incidence (3 of 6 animals) of extensive necrosis was produced by the lowest dose (3.5 g/kg), which had the lowest incidence (1 of 6 animals) of individual cell necrosis. Conversely, a dose of 35 g/kg had a 1-of-6 incidence of extensive necrosis and a 5-of-6 incidence of individual cell necrosis. Further, the increases reported by Lieberman et al. (1) for the three liver enzymes ( Figure 3A and B) are minimal, relative to the high doses administered, and do not appear to be dose related. There is no indication in the figures that the observed values are statistically significantly different from control. Statistical significance is difficult to determine from examination of the figures because of the tremendous variability and the fairly consistent or uniform response across all the doses. The observation in this study that death of the animals occurred 5-8 days after the ip injections of either distillate or CS-D4 indicates that death was not due to a direct toxic effect of the test materials. The delayed deaths are consistent with an infectious process probably related to the quality of the test material or to a highly inflammatory process related to the route and volume of test material administered with a resultant peritonitis. It (11) provide compelling evidence that CS-D4 (and probably other cyclosiloxanes) are extensively metabolized by rats and that metabolism and subsequent elimination of hydrophilic metabolites in urine and feces is an important clearance mechanism from mammalian species. In particular, the rates of metabolism and clearance of CS-D4 and its metabolites (5, 6) suggest that these compounds will not be unusually persistent in mammalian organisms and are inconsistent with the suggestion by Lieberman et al. (1) that these compounds will persist in mice for "at least a year..." in a number of organs and fat.
In summary, this paper [Lieberman et al. (1) ] is deficient in several areas including data interpretation, review of existing and relevant research, and application of basic toxicology principles. The authors have ignored the central paradigm of toxicology as put forth by Paracelsus (12) , which, as paraphrased, states "the dose makes the poison." Judge Sam C. Pointer, Jr., the federal judge overseeing the multidistrict breast implant litigation, appointed an expert scientific panel to review the available data on breast implants. Their toxicology review "reaffirmed the low systemic toxicity of silicone" (13) 
